The story of Viagra and its influence on the pharmaceutical sector presents a challenging question regarding its continued attractiveness as an investment. Initially a remarkable success, generating vast revenues, generic competition has considerably eroded profit margins . While leading pharmaceutical firms continue patents on related therapies an

The outlook of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial porn profits , the expiry in key regions has introduced substantial volatility. Investors are now facing the effect of rival medications , diminishin